A Study of Chidamide Combined With Ivonescimab in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) With Acquired Resistance to Immunotherapy and High Yes-associated Protein (YAP) Expression
Clinical trial NCT07412262 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07412262
- Sponsor
- Guangdong Association of Clinical Trials
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-15
- Primary completion
- 2028-03-31
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.